News from IrsiCaixa

All the news in a click

An IrsiCaixa project to study Long Covid, one of the 9 Catalan proposals selected by the CaixaResearch call for Health Research 2022

HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the new subvariants of Omicron

COVID-19 vaccines: is a second booster necessary at this moment, and for whom?

Study shows that adding a new antiviral to current COVID-19 treatment could reduce mortality in hospitalised patients by 30%

Three IrsiCaixa female researchers receive funding from Gilead to keep progressing in the field of HIV and COVID-19

The IAN Talks are back, the meeting point for IrsiCaixa alumni

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Predicting the progression of SARS-CoV-2 and HIV infection by studying the microbiome

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: